Display Settings:

Format

Send to:

Choose Destination

    Br J Ophthalmol. 2003 Jul;87(7):853-5.

    Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy.

    Goldberg DE, Wang H, Azen SP, Freeman WR.

    Department of Ophthalmology, Shiley Eye Center, University of California San Diego, La Jolla, CA 92093, USA.

    BACKGROUND: Healed cytomegalovirus (CMV) retinitis in the setting of highly active antiretroviral therapy (HAART) is complicated by inflammatory sequelae and vision loss. AIM: To determine the long term visual outcome of AIDS patients with CMV retinitis who received HAART. METHODS: 90 eyes of 63 consecutive AIDS patients with extramacular CMV retinitis were studied prospectively. RESULTS: Immune recovery status was related to time to onset of epiretinal membrane (p=0.05) and cystoid macular oedema (p=0.06) as well as to the incidence of cataract (p=0.001) and moderate vision loss (p<0.0001). Severe vision loss was associated with retinal detachment (p<0.001). CONCLUSION: AIDS patients with extramacular CMV retinitis lose vision while on HAART. HAART related immune recovery is associated with increased frequencies of epiretinal membrane, cystoid macular oedema, cataract, and retinal detachment with resultant vision loss in AIDS patients with healed CMV retinitis.

    PMID: 12812884 [PubMed - indexed for MEDLINE]

    PMCID: 1771778

    Supplemental Content

    Click here to read Click here to read